Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 87

1.

Identification of novel sarcoma risk genes using a two-stage genome wide DNA sequencing strategy in cancer cluster families and population case and control cohorts.

Jones RM, Melton PE, Pinese M, Rea AJ, Ingley E, Ballinger ML; International Sarcoma Kindred Study, Wood DJ, Thomas DM, Moses EK.

BMC Med Genet. 2019 May 3;20(1):69. doi: 10.1186/s12881-019-0808-9.

2.

A novel spheroid-based co-culture model mimics loss of keratinocyte differentiation, melanoma cell invasion, and drug-induced selection of ABCB5-expressing cells.

Klicks J, Maßlo C, Kluth A, Rudolf R, Hafner M.

BMC Cancer. 2019 Apr 29;19(1):402. doi: 10.1186/s12885-019-5606-4.

3.

The influence of nano-TiO2 on metabolic activity, cytotoxicity and ABCB5 mRNA expression in WM-266-4 human metastatic melanoma cell line.

Zdravkovic B, Zdravkovic TP, Zdravkovic M, Strukelj B, Ferk P.

J BUON. 2019 Jan-Feb;24(1):338-346.

4.

Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Capacities.

Sana G, Madigan JP, Gartner JJ, Fourrez M, Lin J, Qutob N, Narayan J, Shukla S, Ambudkar SV, Xia D, Rosenberg SA, Gottesman MM, Samuels Y, Gillet JP.

J Invest Dermatol. 2019 Mar 21. pii: S0022-202X(19)31330-2. doi: 10.1016/j.jid.2019.01.036. [Epub ahead of print]

5.

Immunomagnetic-Enriched Subpopulations of Melanoma Circulating Tumour Cells (CTCs) Exhibit Distinct Transcriptome Profiles.

Aya-Bonilla C, Gray ES, Manikandan J, Freeman JB, Zaenker P, Reid AL, Khattak MA, Frank MH, Millward M, Ziman M.

Cancers (Basel). 2019 Jan 30;11(2). pii: E157. doi: 10.3390/cancers11020157.

6.

The effect of micro-sized titanium dioxide on WM-266-4 metastatic melanoma cell line.

Prunk Zdravković T, Zdravković B, Lunder M, Ferk P.

Bosn J Basic Med Sci. 2019 Feb 12;19(1):60-66. doi: 10.17305/bjbms.2018.3674.

7.

UBE2N Promotes Melanoma Growth via MEK/FRA1/SOX10 Signaling.

Dikshit A, Jin YJ, Degan S, Hwang J, Foster MW, Li CY, Zhang JY.

Cancer Res. 2018 Nov 15;78(22):6462-6472. doi: 10.1158/0008-5472.CAN-18-1040. Epub 2018 Sep 17.

PMID:
30224375
8.

Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines.

Xiao J, Egger ME, McMasters KM, Hao H.

BMC Cancer. 2018 Jun 22;18(1):675. doi: 10.1186/s12885-018-4583-3.

9.

Tribromophenol affects the metabolism, proliferation, migration and multidrug resistance transporters activity of murine melanoma cells B16F1.

de Souza Salgado YC, Boia Ferreira M, Zablocki da Luz J, Filipak Neto F, Oliveira Ribeiro CA.

Toxicol In Vitro. 2018 Aug;50:40-46. doi: 10.1016/j.tiv.2018.02.005. Epub 2018 Feb 8.

10.

Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device.

Aya-Bonilla CA, Marsavela G, Freeman JB, Lomma C, Frank MH, Khattak MA, Meniawy TM, Millward M, Warkiani ME, Gray ES, Ziman M.

Oncotarget. 2017 Jun 27;8(40):67355-67368. doi: 10.18632/oncotarget.18641. eCollection 2017 Sep 15.

11.

Detection of ABCB5 tumour antigen-specific CD8+ T cells in melanoma patients and implications for immunotherapy.

Borchers S, Maβlo C, Müller CA, Tahedl A, Volkind J, Nowak Y, Umansky V, Esterlechner J, Frank MH, Ganss C, Kluth MA, Utikal J.

Clin Exp Immunol. 2018 Jan;191(1):74-83. doi: 10.1111/cei.13053. Epub 2017 Oct 24.

12.

ABCB5 promotes melanoma metastasis through enhancing NF-κB p65 protein stability.

Wang S, Tang L, Lin J, Shen Z, Yao Y, Wang W, Tao S, Gu C, Ma J, Xie Y, Liu Y.

Biochem Biophys Res Commun. 2017 Oct 7;492(1):18-26. doi: 10.1016/j.bbrc.2017.08.052. Epub 2017 Aug 15.

PMID:
28821433
13.

In-vitro study of the influence of octocrylene on a selected metastatic melanoma cell line.

Prunk Zdravković T, Zdravković B, Zdravković M, Dariš B, Lunder M, Ferk P.

G Ital Dermatol Venereol. 2019 Apr;154(2):197-204. doi: 10.23736/S0392-0488.17.05616-4. Epub 2017 Jul 11.

PMID:
28704989
14.

ΔNp73 regulates the expression of the multidrug-resistance genes ABCB1 and ABCB5 in breast cancer and melanoma cells - a short report.

Sakil HAM, Stantic M, Wolfsberger J, Brage SE, Hansson J, Wilhelm MT.

Cell Oncol (Dordr). 2017 Dec;40(6):631-638. doi: 10.1007/s13402-017-0340-x. Epub 2017 Jul 4.

15.

Growth Hormone Receptor Knockdown Sensitizes Human Melanoma Cells to Chemotherapy by Attenuating Expression of ABC Drug Efflux Pumps.

Basu R, Baumgaertel N, Wu S, Kopchick JJ.

Horm Cancer. 2017 Jun;8(3):143-156. doi: 10.1007/s12672-017-0292-7. Epub 2017 Mar 14.

PMID:
28293855
16.

In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells.

Madorsky Rowdo FP, Barón A, von Euw EM, Mordoh J.

Oncol Rep. 2017 Mar;37(3):1367-1378. doi: 10.3892/or.2017.5363. Epub 2017 Jan 13.

17.

Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq.

Gerber T, Willscher E, Loeffler-Wirth H, Hopp L, Schadendorf D, Schartl M, Anderegg U, Camp G, Treutlein B, Binder H, Kunz M.

Oncotarget. 2017 Jan 3;8(1):846-862. doi: 10.18632/oncotarget.13666.

18.

Inhibitor of vasculogenic mimicry restores sensitivity of resistant melanoma cells to DNA-damaging agents.

Vartanian A, Baryshnikova M, Burova O, Afanasyeva D, Misyurin V, Belyаvsky A, Shprakh Z.

Melanoma Res. 2017 Feb;27(1):8-16. doi: 10.1097/CMR.0000000000000308.

PMID:
27776018
19.

Inflammatory regulation of stem-like cells in melanoma.

Lim MS, Wang JH, Power DG, Redmond HP.

Melanoma Res. 2017 Feb;27(1):1-7. doi: 10.1097/CMR.0000000000000303. Review.

PMID:
27764061
20.

Expression of SOX10, ABCB5 and CD271 in melanocytic lesions and correlation with survival data of patients with melanoma.

Gambichler T, Petig AL, Stockfleth E, Stücker M.

Clin Exp Dermatol. 2016 Oct;41(7):709-16. doi: 10.1111/ced.12928.

PMID:
27663144

Supplemental Content

Loading ...
Support Center